Please note that assistive links (commonly known as "skip to links") are used throughout this site. These links are not well-supported by some mobile devices. If you are encountering difficulty using these links, please navigate around these links, or access the site on a desktop browser.
Skip to the primary content of this page Skip to the footer of this page

How Will Physician Medical Group M&A Recover from Covid-19?

Skip to the end of the Expertise Menu

Eric Major was a panelist on’s December Webinar, “How Will Physician Medical Group M&A Recover from Covid-19?”

Thursday, December 10, 2020 | 1:00pm EST

The Physician Medical Group market posted a strong first quarter in 2020. Dental, dermatology and ophthalmology practices were still investor favorites as platform add-on deals, while others were starting or expanding platforms in gastroenterology, allergy/ENT and podiatry. Then the coronavirus disrupted the market, slashing deal volume in half. Investors are back in the PMG market, but activity is cautious.

Join  for an interactive discussion with a panel of healthcare deal advisors and experts as we examine what specialties have been hurt—or helped—by the pandemic, where valuations stand now, and how the pandemic has changed the outlook for 2021.


Lisa Phillips, Editor, (moderator)

Andrew Colbert, Senior Managing Director, Ziegler

Angela Humphreys, Chair, Healthcare Practice Group, Bass, Berry & Sims

Eric Major, Director, Provident Healthcare Partners

View additional details here.